首页> 外国专利> Compositions and methods for the treatment and prevention of infections caused by Staphylococcus aureus bacteria

Compositions and methods for the treatment and prevention of infections caused by Staphylococcus aureus bacteria

机译：用于治疗和预防由金黄色葡萄球菌细菌引起的感染的组合物和方法

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to antimicrobial deoxyribonuclease-based compositions that inhibit growth and proliferation of Staphylococcus aureus bacteria. The present invention also relates to methods of administering the compositions in the treatment and prevention of S. aureus infections. The present invention also relates to methods of administering the compositions in the eradication of S. aureus nasal carriage, in order to prevent the transmission of S. aureus bacteria.

机译：本发明涉及基于抗菌脱氧核糖核酸酶的组合物，其抑制金黄色葡萄球菌细菌的生长和增殖。本发明还涉及在治疗和预防I中给予所述组合物的方法。金黄色葡萄球菌感染。本发明还涉及在根除Is中施用所述组合物的方法。金黄色鼻腔运输，以防止 S的传播。金黄色细菌。 展开▼

著录项

公开/公告号US8765123B1

专利类型

公开/公告日2014-07-01

原文格式PDF

申请/专利权人 JEFFREY B. KAPLAN;
展开▼

申请/专利号US201213609714

发明设计人 JEFFREY B. KAPLAN;
展开▼

申请日2012-09-11

分类号A61K38/47;

国家 US

入库时间 2022-08-21 16:02:23

相似文献

专利

外文文献

中文文献

1. 用于治疗或预防金黄色葡萄球菌感染以及用于根除或减少表面上金黄色葡萄球菌的组合物和方法 [P] . 中国专利： CN102300989B . 2015.12.09

2. 用于治疗或预防金黄色葡萄球菌感染以及用于根除或减少表面上金黄色葡萄球菌的组合物和方法 [P] . 中国专利： CN102300989A . 2011-12-28

3. Compositions and Methods for the Treatment and Prevention of Infections Caused by Staphylococcus aureus Bacteria [P] . 美国专利： US2014170131A1 . 2014-06-19

机译：用于治疗和预防金黄色葡萄球菌细菌感染的组合物和方法

4. Compositions and methods for the treatment and prevention of infections caused by staphylococcus aureus bacteria [P] . 美国专利： US2009130082A1 . 2009-05-21

机译：用于治疗和预防金黄色葡萄球菌引起的感染的组合物和方法

5. COMPOSITIONS AND METHODS FOR TREATMENT OR PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS, AND COMPOSITIONS AND METHODS FOR ERADICATION OR REDUCTION OF STAPHYLOCOCCUS AUREUS ON SURFACES [P] . 日本专利： JP2017057205A . 2017-03-23

机译：用于治疗或预防金黄色葡萄球菌感染的组合物和方法，以及用于根除或减少表面金黄色葡萄球菌的组合物和方法

1. Postoperation of preauricular fistula cellulitis caused by methicillin-resistant staphylococcus aureus infection [J] . Haiyue Tian, Cuiping Zhong 中华耳科学杂志（英文版） . 2018,第003期

2. Correlation between vancomycin MIC values and those of other agents against gram-positive bacteria among patients with bloodstream infections caused by methicillin-resistant Staphylococcus aureus. [J] . Patel N, Lubanski P, Ferro S, Antimicrobial agents and chemotherapy. . 2009,第12期

3. Prevention of percutaneous endoscopic gastrostomy site infections caused by methicillin-resistant Staphylococcus aureus. [J] . Gopal Rao G, Osman M, Johnson L, The Journal of hospital infection . 2004,第1期

4. Bloodstream infections caused by Staphylococcus aureus in a university hospital in Turkey: clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus. [J] . Aygen B, Yoruk A, Yyldyz O, Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2004,第4期

5. Application of silver-chitosan nanoparticles as a prevention and eradication of nosocomial infections due to Staphylococcus aureus sp) [C] . Afrizal Lathiful Fadli, Absari Hanifah, Ana Fitriani, International Conference on Science and Applied Science . 2018

6. Controlling Methicillin Resistant Staphylococcus aureus Hospital Acquired Infections: Clinical Laboratory and Infection Prevention Perspectives. [D] . Henson, Gay. 2013

7. Correlation between Vancomycin MIC Values and Those of Other Agents against Gram-Positive Bacteria among Patients with Bloodstream Infections Caused by Methicillin-Resistant Staphylococcus aureus [O] . N. Patel, P. Lubanski, S. Ferro, 2009

8. Biofilm/Persister/Stationary Phase Bacteria Cause More Severe Disease Than Log Phase Bacteria – II Infection with Persister Forms of Staphylococcus aureus Causes a Chronic Persistent Skin Infection with More Severe Lesion that Takes Longer to Heal and is not Eradicated by the Current Recommended Treatment in Mice [O] . Rebecca Yee, Yuting Yuan, Cory Brayton, 2018

1. Teicoplanin combined with conventional vancomycin therapy for the treatment of pulmonary methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis infections [J] . Wei Wu ,Min Liu ,Jia-Jing Geng . 世界临床病例杂志 . 2021,第034期

2. Treatment of methicillin-resistant Staphylococcus aureus infections:Importance of high vancomycin minumum inhibitory concentrations [J] . Alejandra Morales-Cartagena ,Antonio Lalueza ,Francisco López-Medrano . 世界临床传染病学杂志 . 2015,第2期

3. The Prevalence of Methicillin-Resistant Staphylococcus aureus Colonization in Patients with Complicated Skin and Skin Structure Infections after Treatment with Linezolid or Vancomycin [J] . Laura A. Puzniak ,Kimbal D. Ford ,David B. Huang . 传染病进展（英文） . 2014,第4期

4. Susceptibility of iStaphylococcus aureus/iIsolates Causing Bloodstream Infection to the Antimicrobial Peptide LL-37 [J] . Sinead McNicholaswhj ,Hilary Humphreys ,Deirdre Fitzgerald Hughes . 医学微生物学（英文） . 2013,第1期

5. 临床药师参与2例夫西地酸乳膏用于局部感染耐甲氧西林金黄色葡萄球菌患者的治疗分析 [C] . 林瑶 ,强栓虎 ,薛晓娟 . 中华口腔医学会口腔药学专业委员会第二次全国口腔药学学术会议 . 2013

6. 多功能聚合物/贵金属纳米材料用于治疗细菌感染的研究 [A] . 梅林 . 2014